- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01132950
Contraceptive Awareness and Reproductive Education (CARE)
September 8, 2010 updated by: Memorial Hospital of Rhode Island
Empowering Women to Make Contraceptive Choices While Incarcerated
The purpose of this study is to increase the initiation and continuation of highly effective contraceptive use while incarcerated and upon release, as well as decrease unsafe sexual activity.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Unplanned pregnancies and sexually transmitted infections are important and costly public health problems in the United States resulting from unprotected sexual activity.
Women with a history of incarceration are at increased risk for these problems given the high rates of substance abuse and commercial sex work in this population.
This proposal is designed to evaluate an innovative intervention Motivational Interviewing with Computer Assistance (MICA) designed to improve contraceptive use for incarcerated women who do not want a pregnancy and are soon to be released into the community.
The investigators will utilize the Title X program which, in conjunction with RI Department of Corrections (RI DOC), provides reproductive health services in jail and then transitional services in the community after release.
The investigators plan to recruit 400 women from the RI DOC women's jail and randomize them to two interventions: two sessions of personalized MICA or two sessions of Didactic Educational Counseling (DEC), both delivered individually by trained counselors.
The two counseling interventions will be similar in length and timing, but will vary in content, counseling style and the individualized computer generated feedback that is reviewed with the counselor.
Study Type
Interventional
Enrollment (Anticipated)
400
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Jennifer G Clarke, MD, MPH
- Phone Number: 401-729-3400
- Email: Jennifer_Clarke@mhri.org
Study Locations
-
-
Rhode Island
-
Pawtucket, Rhode Island, United States, 02860
- Recruiting
- Memorial Hospital of Rhode Island
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 35 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Age 18-35;
- Currently sexually active with men defined as having coital sex at least monthly in the past three non-institutionalized months;
- Expected place of residence after release in Providence County or within 15 miles of follow-up site;
- Willing to comply with protocol, follow-up and provide at least one locator;
- Fluent in English.
Exclusion Criteria:
- Inability to give informed consent secondary to organic brain dysfunction, not having own legal guardianship, or active psychosis or otherwise not able to participate in the intervention or assessments (deaf, blind, or impaired communication skills that impair ability to participate in computerize assessment or counseling);
- Pregnant or trying to become pregnant within the next year;
- Hysterectomy, bilateral oophorectomy, tubal ligation, IUD or Essure (coil), implantable contraceptive devices (Implanon) or other procedures which make it very unlikely to become pregnant;
- Women who are monogamous for more than one year whose partner has had a vasectomy;
- Housed in segregation as we will be unable to recruit them for the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Didactic Educational Counseling
|
Participant will watch an educational video while in jail and a second educational video at 3 months post release.
|
EXPERIMENTAL: Motivation Interviewing
Participant will receive two sessions of personalized motivational interviewing.
|
Two personalized sessions of motivational interviewing.
The first one is given while the participant is in jail and the second one is given at 3 months post release.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Contraceptive initiation
Time Frame: 5 years
|
Initiation of a highly effective contraceptive method prior to release from jail will be limited to methods that are 98% or more effective in preventing pregnancy (Table 1).41
Initiation of these methods will be verified through review of the RI DOC medical records (as we have done in the past).
|
5 years
|
Continuous use of highly effective contraceptives at follow-up
Time Frame: 5 years
|
If a participant switches from one highly effective contraceptive method to another she will be recorded as maintaining continuous contraceptive use at follow-up if she switches methods during times when the original method is still effective.
Use of contraceptive methods will be confirmed through both TLFB and medical record review.
|
5 years
|
Incident STIs
Time Frame: 5 years
|
At baseline participants will be tested for T. vaginalis, N. gonorrhoeae, and C. trachomatis through self obtained vaginal swabs.
If a participant is diagnosed with an STI at baseline she will be treated and she will be asked to follow-up in six weeks for a test for cure.
Any positive test after a baseline negative test will be documented as an incident infection.
|
5 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incident pregnancy
Time Frame: 5 years
|
An incident pregnancy will be defined as having occurred if there is a baseline negative pregnancy test and a positive urine Beta-HCG test through the study or a self reported pregnancy confirmed with a positive urine or serum Beta-hCG test through medical record review during the time of study participation.
If a participant reports a positive pregnancy test outside of the study then she will be asked to sign a release of medical information form and a copy of the test results will be obtained.
|
5 years
|
Risk for unintended pregnancy and STIs
Time Frame: 5 years
|
Risk behaviors will be determined through the TLFB.
No or low risk for an unintended pregnancy will include either continuous use of a highly effective contraceptive method, abstinence, or use of a condom with a spermicide during every act of intercourse.
No or low risk for STIs include abstinence or use of a condom with every act of intercourse and with every partner.
|
5 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Jennifer G Clarke, MD, MPH, Memorial Hosptial of Rhode Island
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2009
Primary Completion (ANTICIPATED)
June 1, 2012
Study Completion (ANTICIPATED)
June 1, 2013
Study Registration Dates
First Submitted
May 27, 2010
First Submitted That Met QC Criteria
May 27, 2010
First Posted (ESTIMATE)
May 28, 2010
Study Record Updates
Last Update Posted (ESTIMATE)
September 9, 2010
Last Update Submitted That Met QC Criteria
September 8, 2010
Last Verified
September 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CARE 07-42
- 5R01HD054890 (NIH)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sexually Transmitted Diseases
-
Columbia UniversityNational Institute of Allergy and Infectious Diseases (NIAID)RecruitingSTI | Sexually Transmitted Disease (STD) | Sexually Transmitted Infection (STI)United States
-
National Institute of Allergy and Infectious Diseases...Terminated
-
Boston Medical CenterCompletedSexually Transmitted InfectionUnited States
-
University of ChicagoCompletedSexually Transmitted InfectionUnited States
-
University of California, San FranciscoNational Institute of Mental Health (NIMH); MRC/UVRI and LSHTM Uganda Research... and other collaboratorsCompletedSexually Transmitted InfectionUganda
-
Assistance Publique Hopitaux De MarseilleCompletedSexually Transmitted InfectionFrance
-
University of Illinois at ChicagoEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedHiv | Sexually Transmitted InfectionSouth Africa
-
Boston Medical CenterCompletedSexually Transmitted InfectionUnited States
-
Chinese University of Hong KongRecruitingGonorrhea | Sexually Transmitted InfectionHong Kong
-
Sagami Rubber Industries Co., Ltd.Essential Access HealthCompletedContraception | Prevention of Sexually Transmitted InfectionsUnited States
Clinical Trials on Didactic Educational Counseling
-
University of PittsburghEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedSexually Transmitted Diseases | PregnancyUnited States
-
Weill Medical College of Cornell UniversityRecruitingAutism Spectrum DisorderUnited States
-
University of California, San DiegoNational Institute of Mental Health (NIMH)CompletedHIV Infections | Sexually Transmitted DiseasesMexico
-
The University of Texas Health Science Center at...National Heart, Lung, and Blood Institute (NHLBI)Completed
-
US Department of Veterans AffairsCompleted
-
University of WashingtonNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Michigan State UniversityCompleted
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingBRCA1 Syndrome | BRCA2 Syndrome | No Evidence of Disease | Hereditary Ovarian Carcinoma | Hereditary Female Breast CarcinomaUnited States
-
TriHealth Inc.RecruitingProlapse; Female | Prolapse, Vaginal | Prolapse, UterineUnited States
-
Oregon State UniversitySanofiCompletedType I or Type II Diabetes (Excludes Gestational Diabetes)